Overview

Metabolic Effects of Antipsychotic Substitution in Children

Status:
Withdrawn
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This project aims to identify whether therapeutic substitution of aripiprazole for risperidone or olanzapine, combined with standard nutrition intervention, will impact the metabolic changes associated with antipsychotic treatment in children and adolescents.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
Pfizer
Treatments:
Antipsychotic Agents
Aripiprazole
Olanzapine
Risperidone